Satoshi S. Nishizuka, M.D., Ph.D.


Based on technologies and know-how developed at Iwate Medical University Institute for Biomedical Sciences, Quantdetect, Inc. was launched on April 1, 2021, with the intention of “implementing the research product”. Quantdetect provides assays that have been developed from our original technologies, leading to a safer and fulfilling future.

Company Name Quantdetect, Inc.


TOKYO SANKEI Bldg 27F 1-7-2 Chiyoda, Tokyo 100-0004, Japan
Tel: 03-3242-3146


1-7-35 Chuo-dori, Morioka-shi, Iwate 020-0021 Core Field Morioka 1-3rd floor
Tel: 019-908-8105

Morioka Lab

L1 Advanced Science and Technology Institute of Iwate, 2-4-26
Kitaiioka, Morioka, Iwate 020-0852, Japan
Tel: 019-601-2340 Fax: 019-601-2341

Founder & CEO Satoshi S. Nishizuka
Capital 24.936 million JPY
Business content
  • ・ Supply highly sensitive diagnostic tools for quantifying ctDNA of cancer patients
  • ・ Supply total system for quantifying extremely low level DNA
  • ・ Supply DNA probes for quantifying extremely low level DNA
  • ・ Management for academia-driven patents
  • ・ Planning, production, commercialize, import, and export of international merchandise
  • ・ Medical research consulting